Showing 1191-1200 of 20877 results for "".
- Early Inflammatory Signals May Precede Alopecia Areata Diagnosishttps://reachmd.com/news/early-inflammatory-signals-may-precede-alopecia-areata-diagnosis/2486446/Data from a new systematic review presented at the 2026 American Academy of Dermatology Annual Meeting indicated a consistently elevated neutrophil-to-lymphocyte ratio (NLR) in alopecia areata (AA).Investigators used data from PubMed, Embase, and Cochrane
- EYLEA HD Label Update Enables Extended Dosing Intervalshttps://reachmd.com/news/eylea-hd-label-update-enables-extended-dosing-intervals/2486502/Key Takeaways: The press release reports that the FDA updated the EYLEA HD label to permit consideration of individualized dosing intervals up to ~20 weeks in selected patients after sustained response in wAMD and DME. The announcement cites 96-week da
- Pentanucleotide Instability Observed in MSI-H Colorectal Cancerhttps://reachmd.com/news/pentanucleotide-instability-observed-in-msi-h-colorectal-cancer/2486506/Key Takeaways: The authors report higher rates of combined and locus-specific Penta-C/Penta-D discordance in MSI-H versus MSS colorectal cancers. Penta-D demonstrated greater instability than Penta-C in MSI-H tumors, highlighting locus-specific variabi
- Inpatient Penicillin Allergy Delabeling Scales Across Hospitalshttps://reachmd.com/news/inpatient-penicillin-allergy-delabeling-scales-across-hospitals/2486501/Key Takeaways: Across 40 hospitals in 8 countries, the authors report that positive penicillin DOC results were uncommon and serious adverse events were rare within heterogeneous inpatient protocols. The authors report that bimonthly digital audit-and-
- $1.9M Initiative Supports Early-Career Lupus Researchhttps://reachmd.com/news/19m-initiative-supports-early-career-lupus-research/2486503/Key Takeaways: The announcement describes a joint Lupus Research Alliance–Rheumatology Research Foundation partnership funding round focused on early-career lupus and rheumatology research. Five named investigators and their project titles are listed,
- Systematic Review Examines Vaginal Laser and Radiofrequency for Stress Urinary Incontinencehttps://reachmd.com/news/systematic-review-examines-vaginal-laser-and-radiofrequency-for-stress-urinary-incontinence/2486518/In a systematic review and meta-analysis published in International Urogynecology Journal, investigators reported that energy-based devices may offer modest short-term symptom improvement for women with stress urinary incontinence compared with sham treatment. David Lukanović, Gee
- Tapinarof Shows Rapid Itch and Skin Improvement in Atopic Dermatitishttps://reachmd.com/news/tapinarof-shows-rapid-itch-and-skin-improvement-in-atopic-dermatitis/2486493/New pooled Phase 3 data presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting highlight the rapid onset and consistent efficacy of tapinarof cream 1% (VTAMA; Organon) in patients with moderate-to-severe atopic dermatitis (AD), including children as young as 2 years. Th
- TYK2-JAK1 Inhibitor Treatment Promising for Individuals with Refractory Dermatomyositishttps://reachmd.com/news/tyk2-jak1-inhibitor-treatment-promising-for-individuals-with-refractory-dermatomyositis/2486481/Results from the Phase 3 VALOR trial presented at the American Academy of Dermatology (AAD) 2026 Annual Meeting revealed that individuals with re
- AI-based CCTA plaque quantification vs IVUS: INVICTUS Registry abstracthttps://reachmd.com/news/ai-based-ccta-plaque-quantification-vs-ivus-invictus-registry-abstract/2486488/The INVICTUS Registry abstract describes an automated artificial intelligence workflow for coronary CT angiography plaque quantification being assessed
- AAD 2026: New Study Highlights Dual-Action Antioxidant Serum for UV-Induced Skin Protectionhttps://reachmd.com/news/aad-2026-new-study-highlights-dual-action-antioxidant-serum-for-uv-induced-skin-protection/2486463/New research presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting highlights the potential of a multifunctional antioxidant serum, AOX2.0, to protect human skin from ultraviolet (UV)-induced damage while supporting epidermal recovery. The study examined how oxidative stress